Trifecta Capital Advisors’s Armata Pharmaceuticals ARMP Stock Holding History

Trifecta Capital Advisors’s Portfolio ARMP Stock Details ARMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$2.62K	Hold	714	–	–	﹤0.01%	276
2026 Q2	$4.63K	Hold	714	–	–	﹤0.01%	270
2026 Q1	$7.31K	Hold	714	–	–	﹤0.01%	239
2025 Q4	$4.48K	Hold	714	–	–	﹤0.01%	244
2025 Q3	$2.13K	Hold	714	–	–	﹤0.01%	329
2025 Q2	$1.36K	Hold	714	–	–	﹤0.01%	394
2025 Q1	$1.04K	Hold	714	–	–	﹤0.01%	370
2024 Q4	$1.32K	Hold	714	–	–	﹤0.01%	348
2024 Q3	$1.69K	Hold	714	–	–	﹤0.01%	332
2024 Q2	$1.96K	Hold	714	–	–	﹤0.01%	316
2024 Q1	$2.98K	Hold	714	–	–	﹤0.01%	264
2023 Q4	$2.31K	Hold	714	–	–	﹤0.01%	311
2023 Q3	$2.14K	Hold	714	–	–	﹤0.01%	301
2023 Q2	$814	Hold	714	–	–	﹤0.01%	386
2023 Q1	$1.19K	Hold	714	–	–	﹤0.01%	355
2022 Q4	$885	Buy	+714	New	+$1.86K	﹤0.01%	384

Other funds holding ARMP

SeaCrest Wealth Management Purchase, New York $883M AUM 33.97% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

CNBT

Cornerstone National Bank & Trust Palatine, Illinois $309M AUM 7.69% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return

North Star Investment Management Chicago, Illinois $1.85B AUM 21.53% 1-Year Est. Return

TFG

Team Financial Group Temecula, California $253M AUM 9.36% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return

Trifecta Capital Advisors's ARMP Position: Q3 2026 in Review

Trifecta Capital Advisors held its Armata Pharmaceuticals (ARMP) position steady in Q3 2026 at 714 shares worth $2.62K. The position accounts for ﹤0.01% of the portfolio, ranked #276.

Trifecta Capital Advisors first reported a position in ARMP in Q4 2022 and has held it in 16 quarters since. The position peaked at $7.31K in Q1 2026. 12 funds tracked by Wall St. Rank hold ARMP as of Q3 2026.

Trifecta Capital Advisors held 714 shares of Armata Pharmaceuticals worth $2.62K as of Q3 2026.
Trifecta Capital Advisors left its Armata Pharmaceuticals share count unchanged in Q3 2026.
Armata Pharmaceuticals made up ﹤0.01% of Trifecta Capital Advisors's portfolio in Q3 2026, its #276 holding.
Trifecta Capital Advisors first reported a position in Armata Pharmaceuticals in Q4 2022 and has held it in 16 quarters since.
Trifecta Capital Advisors's Armata Pharmaceuticals position peaked at $7.31K in Q1 2026.
12 funds tracked by Wall St. Rank held Armata Pharmaceuticals as of Q3 2026.

Based on Trifecta Capital Advisors's 13F filing for Q3 2026, filed 21 Oct 2026.